Company Description
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products.
The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products.
The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries.
The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.
The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022.
The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
| Country | United States |
| Founded | 1892 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 53,000 |
| CEO | Peter Arduini |
Contact Details
Address: 500 West Monroe Street Chicago, Illinois 60661 United States | |
| Phone | 833 735 1139 |
| Website | gehealthcare.com |
Stock Details
| Ticker Symbol | GEHC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001932393 |
| CUSIP Number | 36266G107 |
| ISIN Number | US36266G1076 |
| Employer ID | 88-2515116 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Roland Rott | President and Chief Executive Officer of Imaging |
| Peter J. Arduini | President, Chief Executive Officer and Director |
| James K. Saccaro | Vice President and Chief Financial Officer |
| Dr. Taha Kass-Hout M.D., M.S. | Chief Science and Technology Officer |
| Frank R. Jimenez Esq. | Vice President, General Counsel and Corporate Secretary |
| George Andrew Newcomb | Controller and Chief Accounting Officer |
| Jahid Khandaker | Chief Information Officer |
| Carolynne Borders | Chief Investor Relations Officer |
| Rana Strellis | Chief Corporate Marketing and Communications Officer |
| Adam Y. Holton | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 24, 2025 | 8-K | Current Report |
| Jun 9, 2025 | 8-K | Current Report |
| Jun 6, 2025 | SCHEDULE 13G/A | Filing |
| Jun 5, 2025 | 424B2 | Prospectus |
| Jun 4, 2025 | 8-K | Current Report |
| Jun 3, 2025 | FWP | Free Writing Prospectus |
| Jun 3, 2025 | 424B2 | Prospectus |
| May 30, 2025 | 8-K | Current Report |
| May 29, 2025 | SD | Form - SD |
| May 13, 2025 | SCHEDULE 13G/A | Filing |